Büsra Köksoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Büsra Köksoy has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Ibrahim Nahit Sendur
Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Ankara 06230, Türkiye
1 shared publication - Yasemin Hatice Balaban
Division of Gastroenterology, Department of Internal Medical Sciences, Hacettepe University School of Medicine, Ankara, Turkiye
1 shared publication
Latest Publications
- Open Access
- 1 April 2025
- Published by LIDSEN Publishing Inc in OBM Transplantation
- Vol. 09 (02) , 1-22
Cytomegalovirus Management in Solid Organ Transplant Recipients
Cytomegalovirus (CMV) remains a significant cause of morbidity and mortality in solid organ transplant (SOT) recipients. Despite advancements in prophylaxis and antiviral therapy, CMV continues to pose clinical challenges in transplant medicine. This review provides a comprehensive overview of CMV, exploring its pathophysiology, epidemiology, and clinical presentation in SOT patients, in whom CMV infection can lead to direct organ involvement and systemic symptoms. Additionally, CMV has indirect effects, including graft dysfunction and an increased risk of opportunistic infections. We examine the immune responses to CMV, focusing on the roles of both innate and adaptive immunity. The importance of personalized prophylaxis and preemptive therapy is emphasized based on serostatus and individual risk factors. Furthermore, this review discusses resistance mechanisms to standard therapies exploring alternative treatments.
- 1 April 2025
- Published by LIDSEN Publishing Inc in OBM Transplantation
- Vol. 09 (02) , 1-22
Open AccessCytomegalovirus Management in Solid Organ Transplant Recipients
Cytomegalovirus (CMV) remains a significant cause of morbidity and mortality in solid organ transplant (SOT) recipients. Despite advancements in prophylaxis and antiviral therapy, CMV continues to pose clinical challenges in transplant medicine. This review provides a comprehensive overview of CMV, exploring its pathophysiology, epidemiology, and clinical presentation in SOT patients, in whom CMV infection can lead to direct organ involvement and systemic symptoms. Additionally, CMV has indirect effects, including graft dysfunction and an increased risk of opportunistic infections. We examine the immune responses to CMV, focusing on the roles of both innate and adaptive immunity. The importance of personalized prophylaxis and preemptive therapy is emphasized based on serostatus and individual risk factors. Furthermore, this review discusses resistance mechanisms to standard therapies exploring alternative treatments.